Abstract Using Raman and infrared spectroscopy, we monitored spectral changes occurring in the blood plasma of patients with Alzheimer's disease (AD) in relation to healthy controls. The protein secondary structure as reflected by amide I band involves β-sheet enrichment, which may be attributable to Aβ peptide formation and to increasing proportion of the globulins that are β-sheet rich. Likewise, the behavior of the infrared 1200-1000-cm −1 region and the Raman 980-910-and 450-400-cm
Introduction
Alzheimer's disease (AD) is an age-related neurological disorder of the brain characterized by a progressive loss of memory and decline in cognitive function. The pathological hallmarks of AD include accumulation of β-amyloid peptides (Aβ) around the neurovasculature and in the neuropil [1] , neurofibrillary tangles consisting of a hyperphosphorylated microtubule-associated protein called tau [2, 3] , brain inflammation, and neurovascular stress [4] . This disease is characterized morphologically by an overall loss of synapses and neurons and an overall reduction in brain volume [5] . Diagnosis of AD is time consuming and requires a combination of psychological testing, imaging, and exclusion of other neurological disorders. The identification of peripheral biomarkers of the disease process leading to an effective and early diagnostic test for AD would allow for presymptomatic detection of the disease and would be valuable for monitoring the efficacy of disease interventions during clinical trials.
Currently, cerebrospinal fluid (CSF) has provided the most promising source of validated AD biomarkers related to Aβ and tau protein [6, 7] . Compared with CSF, however, blood analysis has advantages as an approach to population-based disease screening because it is simpler and less invasive. In this connection, plasma is a complex body fluid containing proteins, peptides, lipids, and metabolites that reflect physiological activity and pathology in various body organs, including the central nervous system (CNS) [8] . In humans, about 500 ml of CSF is absorbed into the blood daily [9] , making blood plasma a suitable source of neurodegenerative disease biomarkers. Some proteins have been identified as potential plasma biomarkers of AD, for instance α-1-antitrypsin, vitamin D-binding protein, inter-α-trypsin inhibitor family heavy chain-related protein, and apolipoprotein J precursor using liquid chromatography and mass spectrometry [10] . In addition, extracellular senile plaques and intracellular neurofibrillary tangles are considered to be the central pathologic features of AD. The most part of the Aβ peptide in plasma is bound to albumin and other proteins, and very little Aβ peptide is free [11, 12] .
Feasible techniques to detect these markers are also of great interest. Structural neuroimaging techniques such as magnetic resonance imaging (MRI) and positron emission tomography (PET) have proven to be valuable in the differential diagnosis of AD [13] , but they are generally expensive, and the availability of instrumentation is not widespread. Several routine methods such as Western blotting require complex preparation steps besides bad accuracy and high costs, which embarrass their clinical applications. However, among other diagnostic techniques in laboratory researches, Raman and infrared spectroscopies (vibrational spectroscopy) have the advantages of being fast, noninvasive, and reliable. High-quality vibrational spectra can reflect structural and electronic properties of molecules and their surroundings, so they can be considered to be Bfingerprints^of the specific molecular species in such a way that protein changes in plasma may yield diagnostic spectra on vibrational spectroscopy [14] . In other words, the accurate detection of the alterations in peripheral blood plasma may be significant for the early diagnosis of AD. In a previous paper [15] , some plasma spectral parameters as potential biomarkers of AD were evaluated by means of sample classifications through discriminant analysis. Herein, we describe the infrared and Raman spectral changes occurring in the course of AD in terms of changes in the composition of blood plasma.
Materials and methods

Subjects
This research was carried out with 50 patients affected by AD and with 14 age-matched healthy controls, collected and diagnosed by the AD Research Unit of BCentro Alzheimer Fundación Reina Sofia^and by the Neurology Department of BHospital 12 de Octubre^in Madrid. Clinical diagnosis of AD was performed according to the criteria of the DMS III-R and NINCDS-ADRDA [16] . [17] .
Blood plasma sampling
Whole blood (4 ml/subject) was collected by venipuncture in heparinized tubes (BD Vacutainer) and centrifuged at 1700g for 10 min at 4°C. The upper layer of the whole plasma containing platelets was collected with a pipette.
On the other hand, platelet-rich plasma (PRP) and plateletpoor plasma (PPP) were prepared as follows: Whole blood (4 ml/subject) was collected by venipuncture in blood collection tubes (BD Vacutainer) containing sodium citrate at 3 %. The tubes were centrifuged at 2280g for 5 min at 4°C. The upper layer is the PRP and was transferred to an empty tube, and 1.5 ml of PRP was then centrifuged at 17,000g for 15 min at 4°C. The supernatant portion of the volume is composed of PPP.
After collection of whole blood (4 ml/subject) in BD Vacutainer tubes containing no anticoagulant, the blood was allowed to clot by leaving it undisturbed at room temperature. This usually takes 15-30 min. The clot was removed by centrifuging at 1000-2000g for 10 min in a refrigerated centrifuge. The resulting supernatant is designated as serum.
About 5 μl of freshly prepared plasma was deposited on a ZnSe window and allowed to evaporate at room temperature in order to obtain a thin film for subsequent infrared spectroscopy measurements. Alternatively, 40 μl of blood plasma or serum was placed on a glass slide and allowed to dry at room temperature. The resulting solid residue was ground in an agate mortar for Raman spectroscopy analysis.
Blood plasma components
Albumin from human serum; γ-globulins from human blood; globulins Cohn fraction IV human (predominantly α-and β-globulins); α 1 -antitrypsin, α 1 -antichymotrypsin, and transferrin (all three from human plasma); human ubiquitin; and Lhomocysteine were acquired from Sigma-Aldrich. The β-amyloid peptides Aβ and Aβ were purchased commercially from AnaSpec, Inc.
Raman measurements
The spectra of dry plasma samples and plasma components were excited with a 1064-nm Nd:YAG laser line and recorded on a Bruker RFS 100/S FT spectrometer. The scattered radiation was collected at 180°to the source, and frequencydependent scattering of the Raman spectra that occurs with this spectrometer was corrected by multiplying point by point with (ν laser /ν) 4 . Reported frequencies are accurate to ±0.5 cm
, as deduced from frequency standards measured in the spectrometer. Raman spectra were resolved at 4-cm
resolution with a liquid nitrogen-cooled Ge detector. The samples were illuminated by laser power at 100 mW to record 500 scans for each sample. Raman spectra were processed using Opus 2.2 (Bruker, Karlsruhe, Germany) and Grams/AI (Thermo Electron Corporation, USA) software.
The amide I band was used as internal standards for normalization of the spectra. Assignment of the visible bands to vibrational modes of peptide backbone or amino acid side chains was carried out through comparison to Raman spectra measured from plasma proteins and amyloid peptides (Aβ and Aβ ), as well as through comparison to model polypeptides or monographs of Raman spectra of proteins [18, 19] . The intensity values of Raman bands from various atomic groups were determined after spectral normalization.
Infrared measurements
Each blood plasma sample of around 5 μl was deposited on a ZnSe window, spread with a spatula, and allowed to evaporate at room temperature. Similarly, dry films of plasma components on ZnSe windows were prepared from appropriate aqueous solutions or suspensions. The infrared spectra of the resulting films were measured with a Perkin-Elmer 1725X interferometer with 2-cm −1 resolution and obtained as an average of 32 scans. The spectral contributions from residual water vapor in the sample chamber were eliminated using a set of water vapor spectra measured under identical conditions. The subtraction factor was varied until the nonabsorbing region above the 1800-cm −1 region was featureless, and the resulting spectrum was subsequently smoothed with a 9-point Savitsky-Golay function to reduce the noise. Spectral data were treated with the GRAMS/AI software (Thermogalactic) which includes baseline correction, smoothing, spectral subtraction, Fourier self-deconvolution, and derivative programs. Second derivative spectra were obtained with Savitsky-Golay derivative function software for a seven-data point window. 
Data analysis
Diagnostic models were constructed with the spectral parameters alone or combining these predictor variables using discrimination analysis method of the SPSS Statistics 19.0 software (SPSS Inc., Chicago, IL, USA). The predictive model that provides the best discrimination among AD patients and healthy controls is composed of the discriminant function based on the linear combination of predictor variables (spectral parameters). The diagnostic models were cross-validated by the leave-one-out method and assessed by area under the curve (AUC) value of the receiver operating characteristic (ROC) curves.
Results and discussion
Raman analysis
Proteins are the most abundant substances in blood plasma by weight, and hence, the Raman spectrum of blood plasma is dominated by bands generated by protein backbone and side chains. The backbone vibrational mode usually expressed as amide I appears as an intensity maximum near 1658 cm −1 which is accompanied by a shoulder at 1671 cm −1 (Fig. 1A , Table 1 ). There is a large body of experimental and theoretical data that allows assignments of the individual amide I band components to various secondary structure elements of proteins [18, 19] , and accordingly, the 1658-cm −1 maximum can be assigned to protein α-helical structure. One of the major categories of plasma proteins corresponds to albumins, which are the most abundant plasma proteins. Human serum albumin in blood plasma is an α-helical protein (67 % α-helix) consisting of a single polypeptide chain of 585 amino acids that form a heart-shaped protein with three homologous domains (I-III) [20, 21] . Thus, on the said basis, the 1658-cm
maximum is mainly attributable to albumin. Besides, the accompanying 1671-cm −1 shoulder (Fig. 1A , Table 1 ) can be assigned to protein β-structure according to well-established spectrum-structure correlations [18, 19] . Globulins, which can be subdivided into three classes from smallest to largest in Values between parentheses correspond to areas under their respective ROC curves (AUC)
NA normalized area, F frequency, CFIV Cohn fraction IV, Aβ Aβ-amyloid peptides a Predominantly α-and β-globulins molecular weight into alpha, beta, and gamma globulins, constitute the second major fraction of plasma proteins. Abundant α-and β-globulins such as α 1 -antitrypsin, α 2 -macroglobulin, and transferrin are β-sheet-rich proteins, as shown by X-ray studies [22] [23] [24] . The same can be said for IgG protein as a major fraction of γ-globulin [25] . This is also supported by the spectra of human globulins Cohn fraction IV (predominantly α-and β-globulins), α 1 -antitrypsin, transferrin, and γ-globulin (Fig. 1B) , which exhibit a strong amide I band component near 1671 cm −1
. Western blotting confirmed elevated levels of α 2 -macroglobulin in the plasma of AD patients [9] , and this protein has also been found in amyloid plaques in AD [26, 27] . Elevated plasma α 1 -antitrypsin levels in AD patients have been validated by enzyme-linked immunoassay (ELISA) [10] . α 1 -Antitrypsin has also been shown to be present in brain neurofibrillary tangles and senile plaques [28] , and transferrin as oxidized glycoprotein has been found in AD plasma [29] . Besides, IgG levels have been found to be higher in AD plasma compared with healthy individuals [30] . Therefore, the increase of the 1671-cm −1 shoulder relative to the 1658-cm −1 maximum in the course of AD (Fig. 1A ) may be due to increasing of globulins/albumin ratio. Moreover, proteins show a Raman band near 938 cm
which has been correlated with the amount of α-helical structure [31, 32] and was tentatively assigned to the N-C α -C skeletal mode of protein backbone [33] . Detailed normal mode analyses of α-helical polypeptides showed that this vibration contains contributions from C-N and N-C α stretchings and C-N-C α deformation [34] . Thus, α-helical decrease associated with progression of AD as reflected by the 980-910-cm
spectral profile ( Fig. 2A , Table 2 ) is consistent with the said intensity changes of amide I band and, likewise, may also be explained in terms of increasing of globulins/albumin ratio (Fig. 2B , Table 2 ). Other Raman bands sensitive to AD are those located in the 760-740-cm −1 range and can be attributable to the indole-ring breathing mode of tryptophan side chain [35] (758 cm
) and pyrrole units in the heme structure of cytochrome c [36] (744 cm −1 ). The intensity of the tryptophan vibrational mode at 758 cm −1 seems to be dependent on the environment polarity, hydrogen bond strength, and cation-π interactions that can be present in proteins [35] . The spectral changes observed in the course of AD consist of frequency upshifting of the 744-cm −1 band and intensity increase of the band located at 758 cm −1 (Fig. 3A) . Although the intensity increase of the 758-cm −1 band can be generated by the increase of the proportion of globulins (Fig. 3B) as described above, the frequency upshifting of the 744-cm −1 band from healthy controls may be explained as due to changes in platelets from AD patients. In fact, the relative intensity at 744 cm −1 appears as a maximum for healthy control plasma containing platelets (Fig. 3) or PRP (Fig. 4) but not in serum and PPP. In addition, unlike plasma or PRP, no significant frequency upshifting in the course of AD is observed for the band falling in the 746-750-cm −1 range of serum and PPP (Fig. 4) . Therefore, the said band component at 744 cm −1 and frequency upshifting may be attributable to platelets which are absent in serum and very scarce in PPP. In this connection, it has been established that platelet structure and function in AD is altered compared to normal control subjects [37] [38] [39] , which may generate the said frequency upshifting. Thus, AD research can also be focused on platelets as a key peripheral element to diagnose and understand the pathogenesis of AD.
The spectral region between 450 and 400 cm −1 (Fig. 5) comprises bands assigned to δC Table 1) that are sensitive to the presence of the β-sheet structure. In fact, on the basis of plasma component spectra normalized by the amide I band (Fig. 5B) , the greatest contribution to the 409-cm −1 intensity stems from Aβ-amyloid peptides. Accordingly, the 409/423 intensity ratio may be useful as a biomarker for the presence of these peptides in plasma from AD patients (Fig. 5A) . Figure 6A shows the amide I band mean spectra of healthy controls and patients with moderate AD. The most prominent spectral difference is located approximately in the 1640- The 1200-to 1000-cm −1 region of (A) mean infrared spectra of blood plasma from healthy controls (solid line) and patients with moderate AD (dashed line) and (B) infrared spectra of albumin (Alb), globulins Cohn fraction IV (Glob-CFIV), γ-globulin (γ-Glob), 
Infrared analysis
1625-cm
−1 range where protein β-structure used to appear [40] . In order to resolve the overlapping band components under the amide I contour, the corresponding second derivative spectra were calculated and shown in the bottom of Fig. 6A . In the AD spectrum, the higher intensity near 1631 cm −1 relative to healthy controls can be attributable to the formation of Aβ-amyloid peptides on the basis of the infrared spectra from AD brain tissue [41] . Moreover, the spectra of Aβ peptides measured in this study exhibit their amide I absorption maxima at this frequency (Table 1 , Fig. 6B ). On the other hand, the increasing intensity of the 1638-cm −1 band during AD (Fig. 6A) can be ascribed to the β-sheet-rich proteins that generate their amide I vibrational mode near this frequency, such as the globulins whose infrared spectra are shown in Fig. 6B (Table 1) . Thus, the infrared spectral changes in the amide I region when comparing healthy controls and AD patients are consistent with the Raman spectra and may be explained in terms of increase of the proportions of globulins and Aβ peptides. A sensitivity improvement in the visualization and quantitation of the amide I band components by reducing their bandwidth is provided by second derivative spectroscopy. A degree of quantitative analysis would be expected in principle from the second derivative spectra since the peak height is proportional to the original peak height and inversely proportional to the square of the original half-width [42] . Under these conditions, the areas of the amide I band components centered at 1638 and 1631 cm −1 were measured as described elsewhere [15] .
Another spectral region which is sensitive to AD is located between 1200 and 1000 cm −1 (Fig. 7A) . Generation of highly reactive secondary products of lipid peroxidation may contribute to cellular damage, and therefore, measurement of these products has been commonly used to assess oxidative stress/ injury. Hydroxyl compounds (for instance, isoprostanes, 
Values between parentheses correspond to areas under their respective ROC curves (AUC)
A normalized area, CFIV Cohn fraction IV, Aβ Aβ-amyloid peptides a Predominantly α-and β-globulins hydroperoxides) are products of lipid peroxidation and have been reported as markers of oxidative damage in AD [8] . Therefore, the area increasing under the 1200-1000-cm
spectral profile may be attributable to C-O stretching vibrations of hydroxyl compounds stemming from lipid peroxidation. Furthermore, the said area increasing in the course of AD may also be due to νC-O bands from carbohydrate moieties in plasma globulins, as shown in Fig. 7B . This spectral change is accompanied by the increase of the I 1156 /I 1171 intensity ratio in AD, which has been measured as infrared spectral parameters used for AD diagnosis.
Validation of spectral parameters as potential biomarkers of AD
To validate the significance of the above spectral parameters as potential AD biomarkers, ROC curves were plotted assuming that the levels of these parameters follow normal distributions in two groups. An experimental measure of diagnostic test accuracy [43] is provided by the AUC, which is calculated using the trapezoidal rule. As shown in Fig. 8 , the linear combination of Raman and infrared spectral parameters displayed the highest AUC value of 0.94 when compared with the Raman I 758 /I 744 intensity ratio (0.87) and the other Raman and infrared parameters alone (Tables 2 and 3 ). This indicates that, within a binary classification scheme provided by the discriminant function, a randomly selected positive case has a 94 % probability of obtaining a higher score than a randomly selected negative case [44] . Thus, the AUC is an experimental measure of test accuracy [44] , and on the basis of linear discrimination analysis and subsequent ROC curve of combined Raman and infrared spectral parameters, the discrimination accuracy is about 94 %. In addition, the discriminant function of these combined parameters provided a similar percentage of cross-validated cases correctly classified. These data imply that the diagnostic model combining the said spectral parameters possesses improved sensitivity and can identify those patients who missed the diagnosis of AD by using the above spectral parameters alone. On the basis of the Raman spectra of blood serum, an artificial neural network (ANN) classification model has been used for the differential diagnosis of AD [45] . Although its overall accuracy (95 %) was very similar to the best discrimination accuracy described above, our model is expected to be more robust for the following reasons. Firstly, the number of AD cases and healthy controls studied here is significantly higher (50 patients affected by AD and 14 agematched healthy controls); secondly, we have combined two vibrational spectroscopic (Raman and infrared) techniques; and thirdly, unlike the said ANN work, spectral changes have been described here in terms of particular proteins whose relative contents can vary in the course of AD. Finally, in a previous work, we used infrared analysis of mononuclear leukocytes in peripheral blood to diagnose AD [46] . However, the procedure described here for AD diagnosis is advantageous for two reasons. Firstly, preparation of blood plasma is less laborious than that of mononuclear leukocytes, and secondly, the combination of infrared and Raman spectroscopies provides significantly higher accuracy in sample classifications than the use of only infrared spectra of mononuclear leukocytes.
Conclusions
The use of Raman and infrared spectroscopy for the analysis of blood plasma has revealed the main spectral features of this blood fraction extracted from AD patients, namely, stronger intensity of globulin and Aβ-peptide bands when compared with age-matched healthy controls. Another spectral change occurring during AD corresponds to the frequency upshifting of the Raman band located near 744 cm −1 and is attributable to platelets, which are present in the blood plasma studied here. Particularly, this band may be assigned to platelet mitochondrial cytochrome c, which shows a strong intensity band near this frequency generated by a vibrational mode of the pyrrole units in heme structure [36, 47, 48] . Using ROC curves, we can differentiate AD plasma from the healthy one with a diagnostic accuracy of about 94 %. Further work will be focused on measuring more spectral data from more AD and healthy blood specimens to further verify the reliability of this potential detection method for clinical application.
